Vascular Biogenics Ltd.
(NASDAQ : VBLX)

( )
VBLX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.71%194.081.3%$552.04m
GILDGilead Sciences, Inc.
-0.96%65.880.9%$365.15m
ALXNAlexion Pharmaceuticals, Inc.
1.06%108.542.0%$324.86m
ILMNIllumina, Inc.
-0.01%300.893.5%$300.98m
BIIBBiogen Inc.
-0.22%236.121.3%$287.87m
CELGCelgene Corporation
-0.02%98.381.3%$282.84m
AAgilent Technologies, Inc.
-1.01%77.111.6%$191.08m
SRPTSarepta Therapeutics, Inc.
1.19%87.0214.7%$182.45m
VRTXVertex Pharmaceuticals Incorporated
1.49%177.551.9%$176.25m
REGNRegeneron Pharmaceuticals, Inc.
1.52%285.892.6%$174.13m
EXASExact Sciences Corporation
-2.16%104.4124.1%$129.19m
ACADACADIA Pharmaceuticals Inc.
8.80%44.0113.9%$107.31m
INCYIncyte Corporation
2.50%78.342.5%$85.51m
BMRNBioMarin Pharmaceutical Inc.
2.15%74.214.3%$77.79m
NKTRNektar Therapeutics
5.52%21.225.5%$63.53m

Company Profile

Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of first-in-class treatments for cancer. It offers different programs for cancer and inflammatory disease patients such as vascular targeting system and Lecinoxoids. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.